BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

Australia’s Monash University Launches Boston Hub to Accelerate Global Biotech Partnerships

Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. Monash University, Au...

October 06, 2025 | News

HKUST Uncovers Genetic Variant Driving Alzheimer’s Risk Among Ethnic Chinese

A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 ...

October 06, 2025 | News

Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology

MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...

October 06, 2025 | News

Nanyang Biologics to Go Public Through Business Combination with RF Acquisition Corp II Valued at 1.5 Billion USD

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform ...

October 03, 2025 | News

Redefining Cancer Care in Southeast Asia: Siemens Healthineers’ Fabrice Leguet on Turning Awareness into Action

Cancer care in Southeast Asia stands at a critical crossroads. While awareness of early detection is high, the translation into meaningful action remains p...

October 01, 2025 | Interaction | By arcilla.fran@biopharmaapac.com

Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...

October 01, 2025 | News

Olympus Launches OLYSENSE™ AI Endoscopy Portfolio in US and Europe

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today ann...

October 01, 2025 | News

Pier 88 Health and Theranica Secure NMPA Approval for Nerivio® REN Wearable in China

Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greate...

September 30, 2025 | News

Lupin To Acquire VISUfarma To Expand European Specialty Ophthalmology Presence

Global pharma major Lupin Limited announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acqui...

September 30, 2025 | News

Lumonus Partners With Smarter Radiation Oncology® to Expand AI-Driven, Standardised Cancer Care Worldwide

Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, announced a multi-year agreement with Smarter Radiation Onc...

September 30, 2025 | News

AbbVie Submits FDA Application for Tavapadon After Positive Phase 3 TEMPO Results in Parkinson’s Disease

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive r...

September 29, 2025 | News

COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients

COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...

September 29, 2025 | News

ASCP Launches Performance and Diagnostics Insights to Elevate Laboratory Benchmarking and Patient Care

- The American Society for Clinical Pathology (ASCP) has launched Performance and Diagnostics Insights (PDI), a groundbreaking platform designed to transfo...

September 29, 2025 | News

Desert Harvest Launches First Menopause Supplement with Human-Identical Lactoferrin

Desert Harvest, a clinically trusted leader in pelvic and hormonal wellness, announced the launch of the first menopause supplement to feature human-i...

September 29, 2025 | News

Stay Connected